This study is to assess the onset of action of fixed drug combination of azelastine
hydrochloride and fluticasone propionate nasal spray (Dymista) in treating the nasal symptoms
of seasonal allergic rhinitis (SAR) induced by an allergen challenge in an Environmental
Exposure Unit (EEU).